RS59301B1 - Derivati imidazopiridazina kao pi3kbeta inhibitori - Google Patents

Derivati imidazopiridazina kao pi3kbeta inhibitori

Info

Publication number
RS59301B1
RS59301B1 RSP20191225A RS59301B1 RS 59301 B1 RS59301 B1 RS 59301B1 RS P20191225 A RSP20191225 A RS P20191225A RS 59301 B1 RS59301 B1 RS 59301B1
Authority
RS
Serbia
Prior art keywords
seal
valve
ball
radial
axial
Prior art date
Application number
Other languages
English (en)
Inventor
Laurence Anne Mevellec
Lieven Meerpoel
Sophie Coupa
Virginie Sophie Poncelet
Isabelle Noëlle Constance Pilatte
Elisabeth Thérèse Jeanne Pasquier
Didier Jean-Claude Berthelot
Olivier Alexis Georges Querolle
Christophe Meyer
Patrick René Angibaud
Christophe Gabriel Marcel Demestre
Guillaume Jean Maurice Mercey
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of RS59301B1 publication Critical patent/RS59301B1/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Taps Or Cocks (AREA)

Description

PLASTIČNI LOPTASTI VENTIL SA RADIJALNO - AKSIJALNIM
ZAPTIVAČEM
Oblast tehnike na koju se pronalazak odnosi
Pronalazak pripada oblasti armature za hemijsku industriju.
Tehnički problem
Pronalazak rešava problem zaptivanja plastičnih loptastih ventila ali na drugačiji, jednostavniji način nego kako se to do sada radilo.
Stanje tehnike
Postojeći plastični loptasti ventili u kućištu imaju deo, nosač zaptivača, na kome se nalaze tri zaptivača. Prvi je najčešće od teflona, naleže na loptu ventila i nije bitan za ovo razmatranje, drugi je od kiselootporne gume ili vitona i naleže na kućište ventila (radijalno statičko zaptivanje) a treći, koji je takođe od kiselootporne gume ili vitona, naleže na spojnicu ventila za koju se spaja cevovod (aksijalno statičko zaptivanje). Sa tim zaptivačima, izuzimajući zaptivač vratila ventila koji takođe nije bitan za ovo razmatranje, plastičnim loptastim ventilima omogućeno je normalno funkcionisanje uz zaptivanje svih mesta gde mogu nastati procurivanja van ventila. Znači, ovakva konstrukcija plastičnih loptastih ventila, a za ovo razmatranje bitna, ima dva mesta na kojima se sa dva zaptivača sprečava procurivanje.
Izlaganje suštine pronalaska
Pronalazak se sastoji od spojnice (1), holenderske navrtke (2), kućišta ventila (3), nosača zaptivača X-4X lopte (5), vratila (6), ručice (7), radijalno - aksijalnog zaptivača od kiselootporne gume ili vitona (8), zaptivača lopte od teflona (9) i zaptivača vratila od kiselootporne gume ili vitona (10).
Kod plastičnog loptastog ventila sa radijalno - aksijalnim zaptivačem kućište ventila i nosač zaptivača su tako konstruisani da se radijalno i alsijalno procurivanje, za razliku od klasičnih plastičnih ventila kod kojih se ono sprečava na dva mesta sa dva zaptivača, ovde sprečava samo najednom mestu i to sa jednim zaptivačem.
Kratak opis slike nacrta
Slika prikazuje četvrtinu preseka gornje polovine plastičnog loptastog ventila sa radijalno - aksijalnim zaptivačem.
Detaljan opis pronalaska
Plastični loptasti ventili nalaze primenu svuda gde se radi sa agresivnim tečnim fluidima a naročito u hemijskoj i farmaceutskoj industriji, u metalurškim kombinatima, u laboratorijama fakulteta i instituta i td
Plastični loptasti ventil sa radijalno - aksijalnim zaptivačem sastoji se od spojnice (1), holenderske navrtke (2), kućišta ventila (3), nosača zaptivača (4), lopte (5), vratila (6), ručice (7), radijalno - aksijalnog zaptivača od kiselootporne gume ili vitona (8), zaptivača lopte od teflona (9) i zaptivača vratila od kiselootporne gume ili vitona (10).
Za rad ventila karakteristična su tri položaja lopte ventila: 1) lopta zatvara ceo otvor u nosaču zaptivača - ventil je zatvoren, 2) lopta zatvara deo otvora u nosaču zaptivača - ventil reguliše protok fluida i 3) lopta uopšte ne zatvara otvor u nosaču zaptivača - ventil je otvoren.
Usled pritiska, agresivni tečni fluid može procuriti van instalacije između spojnice i nosača zaptivača, kada je ventil zatvoren i između kućišta ventila i nosača zaptivača, kada ventil reguliše protok. Da bi se procurivanje sprečilo na ta dva mesta postavljaju se zaptivači od kiselootporne gume ili vitona.
Kod plastičnog loptastog ventila sa radijalno - aksijalnim zaptivačem kućište ventila i nosač zaptivača su tako konstruisani da se radijalno i alsijalno procurivanje sprečava samo na jednom mestu i to sa jednim zaptivačem. To praktično znači da ovde jedan zaptivač istovremeno naleže i zaptiva površine od tri dela, od kućišta ventila, nosača zaptivača i od spojnice pa time sprečava sva procurivanja van ventila.
Način industrijske ili druge primene pronalaska
Pronalazak se može primeniti svuda gde se vrši manipulacija ili skladištenje agresivnih tečnih fluida.

Claims (1)

  1. Plastični loptasti ventil sa radijalno - aksijalnim zaptivačem sastoji se od spojnice (1), holenderske navrtke (2), kućišta (3), nosača zaptivača (4), lopte (5), vratila (6), ručice (7), zaptivača lopte od teflona (9) i zaptivača vratila od kiselootporne gume ili vitona (10),naznačen time,što se zaptivanje između spojnice (1), nosača zaptivača (4) i kućišta ventila (3) ostvaruje samo sa jednim, radijalno - aksijalnim zaptivačem (8) koji istovremeno naleže na površine sva ta tri dela i time sprečava procurivanje agresivnog tečnog fluida van ventila.
RSP20191225 2014-12-19 2015-12-18 Derivati imidazopiridazina kao pi3kbeta inhibitori RS59301B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14199322 2014-12-19
PCT/EP2015/080604 WO2016097347A1 (en) 2014-12-19 2015-12-18 IMIDAZOPYRIDAZINE DERIVATIVES AS ΡΙ3Κβ INHIBITORS
EP15810784.7A EP3233862B1 (en) 2014-12-19 2015-12-18 Imidazopyridazine derivatives as pi3kbeta inhibitors

Publications (1)

Publication Number Publication Date
RS59301B1 true RS59301B1 (sr) 2019-10-31

Family

ID=52134002

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP20191225 RS59301B1 (sr) 2014-12-19 2015-12-18 Derivati imidazopiridazina kao pi3kbeta inhibitori

Country Status (26)

Country Link
US (1) US10087187B2 (sr)
EP (1) EP3233862B1 (sr)
JP (1) JP6568588B2 (sr)
KR (1) KR20170095239A (sr)
CN (1) CN107108634B (sr)
AU (1) AU2015366190B2 (sr)
BR (1) BR112017012930A2 (sr)
CA (1) CA2967551A1 (sr)
CY (1) CY1122381T1 (sr)
DK (1) DK3233862T3 (sr)
EA (1) EA029789B1 (sr)
ES (1) ES2761051T3 (sr)
HR (1) HRP20191550T1 (sr)
HU (1) HUE045220T2 (sr)
IL (1) IL252866B (sr)
LT (1) LT3233862T (sr)
MA (1) MA41174B1 (sr)
MD (1) MD3233862T2 (sr)
ME (1) ME03517B (sr)
MX (1) MX2017008074A (sr)
PL (1) PL3233862T3 (sr)
PT (1) PT3233862T (sr)
RS (1) RS59301B1 (sr)
SI (1) SI3233862T1 (sr)
SM (1) SMT201900509T1 (sr)
WO (1) WO2016097347A1 (sr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6912460B2 (ja) 2015-10-09 2021-08-04 ヤンセン ファーマシューティカ エヌ.ベー. PI3Kβ阻害剤としてのキノキサリンおよびピリドピラジン誘導体
KR102472453B1 (ko) 2016-06-16 2022-11-29 얀센 파마슈티카 엔.브이. Pi3k 베타 저해제로서의 이환식 피리딘, 피라진, 및 피리미딘 유도체
EP3601254B1 (en) 2017-03-29 2022-05-25 Janssen Pharmaceutica NV Quinoxaline and pyridopyrazine derivatives as pi3k-beta inhibitors
JP7637328B2 (ja) 2019-02-07 2025-02-28 ベイジーン リミテッド Tlr7アゴニストとしてのイミダゾ[2,1-f][1,2,4]トリアジン-4-アミン誘導体
CN110128505A (zh) * 2019-05-21 2019-08-16 梯尔希(南京)药物研发有限公司 一种戈舍瑞林杂质的合成方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070078136A1 (en) 2005-09-22 2007-04-05 Bristol-Myers Squibb Company Fused heterocyclic compounds useful as kinase modulators
PE20080403A1 (es) 2006-07-14 2008-04-25 Amgen Inc Derivados heterociclicos fusionados y metodos de uso
US8217177B2 (en) 2006-07-14 2012-07-10 Amgen Inc. Fused heterocyclic derivatives and methods of use
WO2008014219A2 (en) 2006-07-24 2008-01-31 Smithkline Beecham Corporation Thiozolidinedione derivatives as p13 kinase inhibitors
AU2007292924A1 (en) 2006-09-07 2008-03-13 Biogen Idec Ma Inc. IRAK modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder
PE20090215A1 (es) * 2007-05-09 2009-03-30 Novartis Ag Compuestos derivados de imidazopiridazinas como inhibidores de cinasa
WO2009060197A1 (en) 2007-11-08 2009-05-14 Centro Nacional De Investigaciones Oncologicas (Cnio) Imidazopyridazines for use as protein kinase inhibitors
PE20091468A1 (es) * 2008-02-28 2009-10-22 Novartis Ag DERIVADOS DE 3-METIL-IMIDAZO-[1,2-b]-PIRIDAZINA
WO2010007099A1 (en) * 2008-07-15 2010-01-21 Cellzome Limited 2-aminoimidazo[1,2-b]pyridazine derivatives as pi3k inhibitors
MY162604A (en) 2009-08-17 2017-06-30 Intellikine Llc Heterocyclic compounds and uses thereof
DE102009049679A1 (de) * 2009-10-19 2011-04-21 Merck Patent Gmbh Pyrazolopyrimidinderivate
WO2011058109A1 (en) 2009-11-12 2011-05-19 Ucb Pharma S.A. Fused bicyclic pyrrole and imidazole derivatives as kinase inhibitors
UY33304A (es) 2010-04-02 2011-10-31 Amgen Inc Compuestos heterocíclicos y sus usos
ES2616238T3 (es) 2010-10-06 2017-06-12 Glaxosmithkline Llc, Corporation Service Company Derivados de bencimidazol como inhibidores de PI3 quinasa
EP2678016B1 (en) 2011-02-23 2016-08-10 Intellikine, LLC Heterocyclic compounds and uses thereof
US9096605B2 (en) * 2011-08-24 2015-08-04 Glaxosmithkline Llc Pyrazolopyrimidine derivatives as PI3 kinase inhibitors
WO2013095761A1 (en) 2011-12-20 2013-06-27 Glaxosmithkline Llc Imidazopyridine derivatives as pi3 kinase inhibitors
US8778937B2 (en) 2011-12-20 2014-07-15 Glaxosmithkline Llc Benzimidazole boronic acid derivatives as PI3 kinase inhibitors
TWI574962B (zh) * 2012-11-14 2017-03-21 加拓科學公司 作爲pi3激酶調節劑的芳雜環化合物及其使用方法和用途
GB201321734D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents

Also Published As

Publication number Publication date
EP3233862B1 (en) 2019-07-03
ME03517B (me) 2020-04-20
IL252866B (en) 2020-09-30
KR20170095239A (ko) 2017-08-22
BR112017012930A2 (pt) 2018-01-09
HUE045220T2 (hu) 2019-12-30
HRP20191550T1 (hr) 2019-11-29
PT3233862T (pt) 2019-10-09
EA201791396A1 (ru) 2017-10-31
ES2761051T3 (es) 2020-05-18
LT3233862T (lt) 2019-09-10
AU2015366190B2 (en) 2020-01-23
PL3233862T3 (pl) 2020-01-31
CN107108634A (zh) 2017-08-29
CN107108634B (zh) 2020-09-15
US20180002336A1 (en) 2018-01-04
SMT201900509T1 (it) 2019-11-13
JP2017538734A (ja) 2017-12-28
WO2016097347A1 (en) 2016-06-23
SI3233862T1 (sl) 2019-09-30
EA029789B1 (ru) 2018-05-31
CY1122381T1 (el) 2021-01-27
MA41174B1 (fr) 2019-09-30
AU2015366190A1 (en) 2017-05-25
EP3233862A1 (en) 2017-10-25
IL252866A0 (en) 2017-08-31
CA2967551A1 (en) 2016-06-23
MX2017008074A (es) 2018-01-09
JP6568588B2 (ja) 2019-08-28
MA41174A (fr) 2017-10-25
US10087187B2 (en) 2018-10-02
MD3233862T2 (ro) 2019-11-30
DK3233862T3 (da) 2019-10-07

Similar Documents

Publication Publication Date Title
USRE47010E1 (en) Valve and stem sealing assembly
US20200149528A1 (en) Modular Gland Arrangements For A Plug Valve
CN104791512B (zh) 浮动球阀密封件
MX2020007340A (es) Montaje de valvula.
US20140175319A1 (en) Multi-section valve bodies having face seals
CN104421439A (zh) 具有浮动密封件的闸阀
CN110886887A (zh) 一种衬氟球阀
BR112017022518A2 (pt) sistema de vedação tendo elemento de vedação de diâmetro interno de travamento para resistir a mudanças de pressão
US3188049A (en) Gate valve
US20130284963A1 (en) Butterfly Valve and Stem Sealing Assembly
CN103821953A (zh) 蝶阀
GB2532870B (en) Mechanical seal support system
US3206164A (en) Internally trunnioned valve member
CN206496006U (zh) 一种实用性强的截止阀
DE202016006765U1 (de) Rohrventil Coax-Hahn
CN204592329U (zh) 低负载轻型蝶阀
RU2516086C2 (ru) Запорный клапан
ES2467490A1 (es) Dispositivo de sellado hermético para válvulas industriales
RU118384U1 (ru) Клапан угловой
CN205806940U (zh) 阀装置
CN104390021B (zh) 湿氯专用阀
CN204284479U (zh) 湿氯专用阀
CN204717086U (zh) 防逸散磁动闸阀
EP2954239A1 (en) Butterfly valve comprising removable coupling part
CN204004512U (zh) 法兰对夹式球阀